Alexandria Real Estate Equities
ARE
#2158
Rank
A$13.18 B
Marketcap
A$76.06
Share price
-0.06%
Change (1 day)
-48.77%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -A$1.48 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are A$2.94 Billion. a decrease over its 2024 earnings that were of A$0.98 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 -A$1.41 Billion-242.13%
2024 A$0.98 B96.11%
2023 A$0.50 B-53.56%
2022 A$1.08 B-3.96%
2021 A$1.12 B-20.26%
2020 A$1.41 B72.88%
2019 A$0.81 B3.11%
2018 A$0.79 B73.54%
2017 A$0.45 B464.88%
2016 A$80.92 M-77.32%
2015 A$0.35 B36.31%
2014 A$0.26 B-10.81%
2013 A$0.29 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$16.78 B-1,297.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$31.86 B-2,373.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.67 B-932.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$13.99 B-1,098.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.40 B-200.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.37 B-911.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.18 B-113.16%๐Ÿ‡บ๐Ÿ‡ธ USA